JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Acibadem Specialist

Prof. Dr. Tevfik Rifki Evrenkaya

Internal Medicine

33+ years experienceLanguages: Turkish, EnglishOnline consultation
Profile

About Tevfik Rifki Evrenkaya

Prof. Tevfik Rifki Evrenkaya is a seasoned nephrologist and professor with a long-standing commitment to clinical care, education, and research. He completed his professorship training at Gülhane Military Medical Academy, Haydarpaşa Training Hospital in 2007 and has since combined academic roles with clinical practice, including notable service at Acibadem Health Group beginning in 2012. M.D. Evrenkaya’s practice focuses on kidney disease management, dialysis, and transplantation. He is active in professional communities at national and international levels, holding memberships with the Turkish Society of Nephrology, the Turkish Internal Medicine Specialty Society, the Dialysis Physicians Association, the European Dialysis and Transplantation Association/European Renal Association, and the International Society of Nephrology. Known for a patient-centered approach, he brings academic rigor to clinical decision-making and mentors the next generation of physicians while contributing to advancements in nephrology through collaboration and association involvement.

Subspecialties

  • Kidney disease management
  • Chronic hemodialysis
  • Dialysis
  • Kidney transplantation care
  • Cisplatin-induced nephrotoxicity
  • Cyclosporine nephrotoxicity
  • Uremic bone disease
  • Hemodialysis catheter-related bacteremia
  • Temporary hemodialysis catheter infections
  • Arteriovenous fistula insufficiency
  • Ultrafiltration management in hemodialysis
  • Nutritional assessment in hemodialysis patients

Education

  • 2007 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Professor
  • 2000 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Associate Professor
  • 1996 Gulhane Military Medical Academy Nephrology
  • 1993 Gulhane Military Medical Academy Internal Medicine
  • 1986 Gulhane Military Medical Academy Faculty of Medicine

Experience

  • 2012 Acibadem Health Group
  • 2007 – 2012 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Professor
  • 2000 – 2007 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Associate Professor
  • 1997 – 2000 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Assistant Professor
  • 1996 – 1997 Gülhane Military Medical Academy, Haydarpaşa Training Hospital / Nephrology Specialist
  • 1993 – 1994 Ardahan Military Hospital / Internal Medicine Specialist

Professional Memberships

  • Turkish Society of Nephrology
  • Turkish Internal Medicine Specialty Society
  • Dialysis Physicians Association
  • European Dialysis and Transplantation Association/European Renal Association
  • International Society of Nephrology

Selected Publications

  • Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity.Ren Fail 2007;29(3):257-63. Aydinoz S, Uzun G, Cermik H, Atasoyu EM, Yildiz S, Karagoz B, Evrenkaya R
  • The influence of the amount of ultrafiltration in chronic hemodialysis on P wave dispersion Ren Fail. 2007;29(2):207-12. Unver S, Ozmen N, Aparci M, Atasoyu EM, Evrenkaya TR.
  • Risk factors for the infections caused by temporary double lumen haemodialysis catheters. Arch Med Res 2006; 37:348-352. Unver S, Atasoyu EM, Evrenkaya TR, Ardıç N, Özyurt M
  • Effects of comorbidity from AV fistula insufficiency on fistula blood flow rate in hemodialysis patients Dialysis & Transplantation 2006; 35(11): 682-688. Unver S, Atasoyu EM, Evrenkaya TR
  • The role of prolidase activity in the diagnosis of uremic bone disease Ren Fail 2006; 28(4): 271-274. Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M
  • The importance of body flora in catheter-related bacteremia. Dialysis & Transplantation 2006; 35(2): 72-78. Unver S Atasoyu EM, Evrenkaya TR, Ardıç N, Özyurt M
  • Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):150-4. Atasoyu EM, Yildiz S, Cimsit M, Cermik H, Qyrdedi T , Evrenkaya TR, Aktas S , Uzun G , Bilgi O , Gultepe M
  • Subjective global assessment does not correlate with laboratory parameters of nutrition in hemodialysis patients Dialysis & Transplantation 2005; 34 (6): 368-401 Atasoyu EM, Evrenkaya TR, Unver S,
  • Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats Arch Toxicol. 2005 May;79(5):289-293. Atasoyu EM, Yildiz S, Bilgi O, Cermik H, Evrenkaya R, Aktas S, Gultepe M, Kandemir EG.
  • Which are more effective : vinyl alcohol or polysulphone dialyzers? Dialysis & Transplantation 2004 ; 33(8):504-508. Atasoyu EM, Evrenkaya TR, Unver S, Tulbek MY
  • Hospital acquired infections following the 1999 Marmara earthquake Journal of Hospital Infection 2000 ;51(1) Öncül O, Keskin O, Acar HV, Küçükardalı Y, Evrenkaya R, Atasoyu EM, Top C, Nalbant S, Özkan S, Emekdaş G, Çavuşlu Ş, Us MH, Pahsa A, Gökben M
Book an Appointment

Schedule your appointment with Prof. Dr. Tevfik Rifki Evrenkaya

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Prefer to talk now?
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Appointment with Tevfik Rifki Evrenkaya Internal Medicine

Your information stays strictly confidential and is used only to arrange your care.

Departments

Medical Units

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.